Accumulating data indicate that IL-1β activates 2 major downstream effectors, the NF-κB and MAPK pathways, to stimulate the expression of adhesion molecules such as ICAM1 and VCAM1 in diverse cell types including tumor cells, thereby amplifying and sustaining responses to IL-1β (54). Here, VCAM1 is linked to neoplasm.